The study by Fox Chase Cancer Center in US examined tissue samples from lung cancer patients and found that nearly 6 per cent showed signs they may have been driven by a strain of human papillomavirus (HPV) known to cause cancer.
If HPV indeed plays a role in lung cancer in some patients, the next step is to better understand those tumours so they can be treated more effectively.
"The ultimate goal is to determine if we can target our therapies to the specific characteristics of these tumours," said study author Ranee Mehra, attending physician in medical oncology at Fox Chase.
To investigate, she and her colleagues examined 36 tissue samples from people diagnosed with non-small cell lung cancer who had never smoked, part of the Fox Chase Cancer Center Biosample Repository.
The reason they chose non-smokers, Mehra explained, is that smoking is a major cause of lung cancer - but in non-smokers, the explanation is often less obvious.
Although this suggests that HPV drives lung cancer in less than 6 per cent of non-smoker patients, making it a relatively rare occurrence, lung cancer is very common, Mehra noted - killing more than 1 million people every year.
"Given how many patients develop lung cancer, if even a small percentage of those tumours stem from HPV, that ends up being a large number of patients," she said.
It's not clear how HPV reaches the lung, she said; patients may simply breathe it in. And just because these patients have evidence of an HPV infection that does not necessarily mean the infection caused their tumours, Mehra cautioned.
"It could simply be a coincidence that they had both lung cancer and HPV. But the presence of both simultaneously, and the integration of the virus into the tumour's DNA, fuels the hypothesis that they are related," she noted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app